Congress highlights
In this section
This year, over 8,700 people attended the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held on the 26th–28th of October 2022.
At the congress, we invited Professor Bernhard Hemmer, Dr Victoria Leavitt and MS patient advocate Dominic Shadbolt to share their highlights and key insights from presentations and discussions at the event. To hear Professor Hemmer’s and Dr Leavitt’s key insights, click play below.
You can explore new research and insights on MS, key medical updates on treatments and patient-related concerns, as well as interviews with experts and people with MS by simply clicking on the register button or log-in link below.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
We caught up with experts in multiple sclerosis (MS) to gain key insights into topics of particular interest at the congress. Join Professor Bernhard Hemmer and Dr Victoria Leavitt to hear highlights from presentations and discussions at the congress.
Read on below to explore further insights, new research and developments at ECTRIMS 2022.
You can explore new research and insights on MS, key medical updates on treatments and patient-related concerns, as well as interviews with experts and people with MS by simply clicking on the register button or log-in link below.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
This year, over 8,700 people attended the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held on the 26th–28th of October 2022.
At the congress, we invited Professor Bernhard Hemmer, Dr Victoria Leavitt and MS patient advocate Dominic Shadbolt to share their highlights and key insights from presentations and discussions at the event. To hear Professor Hemmer’s and Dr Leavitt’s key insights, click play below.
You can explore new research and insights on MS, key medical updates on treatments and patient-related concerns, as well as interviews with experts and people with MS by simply clicking on the register button or log-in link below.
Expert-led assessment of relevant clinical guidance
Free scientific information and eLearning for healthcare professionals only
Including CME accreditation, podcasts, webinars and over 50 Learning Zones
Medthority is ad free, so you can learn without distraction
Developed by EPG Health for Medthority. This content has been developed independently of the sponsor Novartis Pharma AG, who have had no editorial input into the content. EPG Health received unrestricted educational funding from the sponsor in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content. Opinions expressed by the experts and patient advocate in videos are based on personal/clinical opinions and experience, and are not to be interpreted as representing the opinions or beliefs of Medthority or EPG Health.